Recombinant Human FADD Protein，His

FADD (Fas-associated protein with death domain) is a critical adaptor protein involved in the extrinsic apoptosis signaling pathway, which plays a pivotal role in regulating programmed cell death. Dysregulation of FADD and its associated pathways has been implicated in various diseases, especially in cancer progression, where resistance to apoptosis contributes to tumor growth and metastasis. To better understand FADD's functions and interactions, researchers have focused on generating recombinant FADD proteins using various expression systems. This allows for the study of its structural properties, signaling mechanisms, and interactions with other proteins, such as death receptors and caspases, crucial for apoptosis. Advances in recombinant protein technology have enabled the production of FADD in adequate quantities for functional assays, structural biology studies, and potential therapeutic applications. Furthermore, investigating FADD's role in distinct cellular contexts and its post-translational modifications can provide insights into how apoptotic pathways are regulated and how they can be manipulated for therapeutic benefits in conditions like cancer. Thus, the study of recombinant FADD proteins holds significant promise for uncovering new strategies to selectively induce apoptosis in tumor cells and improve cancer treatment outcomes.